The overall goal of HOPA's education program is to equip oncology pharmacy practitioners with knowledge about current developments and to improve the efficiency of healthcare delivery while maintaining or exceeding the quality of patient care.
In addition to the flagship HOPA Annual Conference, HOPA presents regional conference programming across the country that offer a variety of in-depth clinical education, practice management, and BCOP Recertification offerings.
Welcome to the all-new HOPA Resources where we consider all searches “advanced searches.”
The HOPA Health Policy and Advocacy committee is dedicated to acting as an advocate on behalf of patients as well as representing hematology/oncology pharmacists across the country in legislative and regulatory endeavors.
HOPA is an active and engaged organization that provides crucial education, networking, cutting edge resources and advancement opportunities to our members. Find yourself in HOPA.Join or renew your membership today!
HOPA has teamed up with Medscape Oncology Education to provide a series of educational activities designed for pharmacists who specialize in hematology/oncology as well as those who practice in a broader setting and care for patients with cancer less frequently. The collaboration is called Pharmacist Focus on Oncology.Learn more
October Journal Club – Attend October's Journal Club on October 22 from 12:00–1:00 pm CT.
Latest Issue of HOPA News now available ‒ read about pharmacy and association events, clinical content, and practice management information.
Three downloadable flyers you can give to patients to help them understand oncology pharmacy are now available.
Member Spotlight – news about our members' accomplishments, awards, research endeavors, and speaking engagements.
Darolutamide (NUBEQA, Bayer HealthCare Pharmaceuticals Inc.) for non-metastatic castration-resistant prostate cancer. (with...
Dalteparin sodium (FRAGMIN, Pfizer, Inc.) to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients 1...
Polatuzumab vedotin-piiq (POLIVY, Genentech, Inc.) in combination with bendamustine and a rituximab product for adult patients with...
Ruxolitinib (JAKAFI, Incyte Corporation) for steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric...
Save the date for HOPA Ahead 2020 - March 11–14, 2020 - Tampa, FL.
The 7th Annual Practice Management Course takes place September 13–14, 2019.
BCOP Programming: Specialty Sessions & Updates Course
Now pharmacists can fulfill all of their BCOP recertification education with HOPA— the experts in clinical oncology pharmacy. HOPA recently was awarded status as a BCOP recertification credit provider by the Board of Pharmacy Specialties (BPS), and will now provide 38 credits of education per year in a variety of delivery options.
The HOPA BCOP recertification courses address the four Domains of Oncology Pharmacy Specialty Practice and improve your knowledge and problem-solving skills in each area. These courses provide BCOP-specific assessments for practicing clinical oncology pharmacists with a need for specific disease prevention and treatment knowledge and strategies.Learn More
HOPA has created several patient education videos for you to share with your patients and their families.